Stockreport

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) [Yahoo! Finance]

Alpha Tau Medical Ltd. - Ordinary Shares  (DRTS) 
PDF - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review and feedback from the FDA as each module is submitted - - Module [Read more]